 IRVING, Texas--BUSINESS WIRE--biote Corp. Biote or the Company Nasdaq: BTMD, a high growth, medical practice-building business within the hormone optimization space, will report its financial results for the second quarter ended June 30, 2022, after market close on Tuesday, August 9, 2022. Terry Weber, Chief Executive Officer, and the Companys management will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET on Wednesday, August 10 